Strength
10 mg/mL
Manufacturer
UCB, Inc.NDC
50474087015
Classification
Brand
Dosage Form
SOLUTION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BRIVARACETAMApproval Type
New Drug (NDA)
FDA Application
NDA205838On Market Since
5/12/2016
Pharmacological Classes
Price Statistics
The NADAC for BRIVIACT 10 MG/ML ORAL SOLN has been published 345 times since Nov 20, 2019, and over the history we have for it it has risen 32.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.8087 per ML |
|---|---|
| All-time high | $4.8191 (May 13, 2026) |
| All-time low | $3.6358 (Nov 20, 2019) |
| 52-week high | $4.8191 |
| 52-week low | $4.6945 |
| Median price | $4.3747 |
| Average price | $4.2692 |
| Largest weekly change | +6.9% (Jan 12, 2022) |
| Weeks tracked | 345 |
| Tracking since | Nov 20, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the brivaracetam market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of BRIVIACT 10 MG/ML ORAL SOLN?
The current National Average Drug Acquisition Cost (NADAC) for BRIVIACT 10 MG/ML ORAL SOLN, manufactured by UCB, Inc., is $4.8087 per ML (NDC 50474087015), effective Jun 24, 2026.
How has the price of BRIVIACT 10 MG/ML ORAL SOLN changed over time?
Over the history we have for it, the NADAC for BRIVIACT 10 MG/ML ORAL SOLN has risen 32.3%. It has been tracked across 345 weekly CMS publications since Nov 20, 2019.
What are the highest and lowest recorded NADAC prices for BRIVIACT 10 MG/ML ORAL SOLN?
Since Nov 20, 2019, the NADAC for BRIVIACT 10 MG/ML ORAL SOLN has ranged from a low of $3.6358 (Nov 20, 2019) to a high of $4.8191 (May 13, 2026), with a median of $4.3747 per ML.
Are there cheaper alternatives to BRIVIACT 10 MG/ML ORAL SOLN?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of BRIVIACT 10 MG/ML ORAL SOLN, so no direct lower-cost alternative is listed.
Who manufactures BRIVIACT 10 MG/ML ORAL SOLN?
BRIVIACT 10 MG/ML ORAL SOLN (NDC 50474087015) is labeled by UCB, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification